BrightHeart Announces Voluson™ Solution Store Collaboration to Deliver Expert-Level AI Support Across the Full Prenatal Ultrasound Exam
BrightHeart, a global leader in AI-driven prenatal ultrasound, today announced the availability of its B-Right AI Platform through GE HealthCare’s Voluson™ Solution Store, bringing advanced AI support directly into routine prenatal care. The addition of this AI platform to the Voluson Solution store is poised to improve early detection of congenital defects, reduce diagnostic uncertainty, and ultimately support better outcomes for clinicians, expectant parents and their babies.
BrightHeart Raises €11M Series A to Scale Expert-Level AI Platform for Prenatal Ultrasound
BrightHeart, a global leader in artificial intelligence (AI) solutions for prenatal ultrasound, today announced the closing of an €11 million Series A financing round. The round was co-led by Odyssée Venture and GO Capital, with participation from the Mussallem CHD Alliance, Lift Value, IDAHO HealthTech Club via Side Angels, and founding investor Sofinnova Partners, as well as prominent clinicians and angel investors, including Professor Laurent Salomon, former President of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), and Sacha Loiseau and John Gridley, serial medtech entrepreneurs.
BrightHeart Obtains Third FDA Clearance and PCCP Approval, Becoming First to Offer One Integrated Solution for Real-Time Fetal Heart Documentation and CHD Detection
BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its second device, B-Right Views. This AI powered tool automatically detects the standard views required for second and third-trimester fetal heart ultrasound evaluations within routine anatomy scans. The software supports fetal heart exams by confirming when all recommended views are captured and documented, enabling exam completeness and consistency regardless of operator experience.
BrightHeart Obtains Second FDA Clearance for Expansion of Platform Capabilities - Adding Tablet Support For Fetal Heart Ultrasound Evaluations
BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, announced today the 510(k) clearance for updates to the BrightHeart platform, adds the capability for clinicians to access the BrightHeart analysis in real-time through a cart-side tablet.
BrightHeart Appoints Michael Butchko as Chairman of the Board
BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, is delighted to announce the appointment of Michael Butchko as the new Chairman of the Board, succeeding Anne Osdoit. Previously serving as a board member for BrightHeart, Michael brings a wealth of experience and expertise from his distinguished career, including his tenure as Senior Vice President and General Manager of ultrasound at GE Healthcare, a global leader in ultrasound, and his numerous engagements with healthcare technology innovators.
BrightHeart Welcomes Michael Butchko as an Independent Board Member
BrightHeart, a Paris-based company developing an AI solution for the prenatal detection of congenital heart defects, announced today the appointment of Michael Butchko as an independent board director.
